成纤维细胞生长因子
FGF21型
FGF19型
成纤维细胞生长因子受体
旁分泌信号
细胞生物学
生物
自分泌信号
纺神星
受体
成纤维细胞生长因子受体1
激素
信号转导
内分泌学
化学
生物化学
肾
作者
Sangwon Lee,Jungyuen Choi,Jyotidarsini Mohanty,Leiliane P. Sousa,Francisco Tomé,Els Pardon,Jan Steyaert,Mark A. Lemmon,Irit Lax,Joseph Schlessinger
出处
期刊:Nature
[Nature Portfolio]
日期:2018-01-01
卷期号:553 (7689): 501-505
被引量:219
摘要
Canonical fibroblast growth factors (FGFs) activate FGF receptors (FGFRs) through paracrine or autocrine mechanisms in a process that requires cooperation with heparan sulfate proteoglycans, which function as co-receptors for FGFR activation. By contrast, endocrine FGFs (FGF19, FGF21 and FGF23) are circulating hormones that regulate critical metabolic processes in a variety of tissues. FGF19 regulates bile acid synthesis and lipogenesis, whereas FGF21 stimulates insulin sensitivity, energy expenditure and weight loss. Endocrine FGFs signal through FGFRs in a manner that requires klothos, which are cell-surface proteins that possess tandem glycosidase domains. Here we describe the crystal structures of free and ligand-bound β-klotho extracellular regions that reveal the molecular mechanism that underlies the specificity of FGF21 towards β-klotho and demonstrate how the FGFR is activated in a klotho-dependent manner. β-Klotho serves as a primary 'zip code'-like receptor that acts as a targeting signal for FGF21, and FGFR functions as a catalytic subunit that mediates intracellular signalling. Our structures also show how the sugar-cutting enzyme glycosidase has evolved to become a specific receptor for hormones that regulate metabolic processes, including the lowering of blood sugar levels. Finally, we describe an agonistic variant of FGF21 with enhanced biological activity and present structural insights into the potential development of therapeutic agents for diseases linked to endocrine FGFs.
科研通智能强力驱动
Strongly Powered by AbleSci AI